COMMON STOCK AND STOCK-BASED COMPENSATION PLANS | NOTE 8: COMMON STOCK AND STOCK-BASED COMPENSATION PLANS The Company grants stock options and stock appreciation rights (“SARs”) capped with a ceiling to employees and stock options to non-employee directors of the Company and its subsidiaries and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan to employees of the Company and its subsidiaries. The SAR unit confers the holder the right to stock appreciation over a preset price of the Company’s common stock during a specified period of time. When the unit is exercised, the appreciation amount is paid through the issuance of shares of the Company’s common stock. The ceiling limits the maximum income for each SAR unit. SARs are considered an equity instrument as it is a net share settled award capped with a ceiling (400% for SAR grants). The options and SARs granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options and SARs granted to employees under stock incentive plans vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. Options granted to non-employee directors vest 25% of the shares underlying the option on each anniversary of the option grant. A summary of the Company’s stock option and SARs activities and related information for the six months ended June 30, 2016, are as follows: Number of Weighted Weighted Outstanding as of December 31, 2015 2,406,455 $ 18.15 Granted — — Exercised (520,059 ) 14.74 Forfeited or expired (28,300 ) 17.83 Outstanding as of June 30, 2016 (2) 1,858,096 $ 19.11 4.3 $ 15,461,017 Exercisable as of June 30, 2016 (3) 1,312,950 $ 19.96 3.7 $ 9,944,437 (1) The SAR units are convertible for a maximum number of shares of the Company’s common stock equal to 75% of the SAR units subject to the grant. (2) Due to the ceiling imposed on the SAR grants, the outstanding amount equals a maximum of 1,639,795 shares of the Company’s common stock issuable upon exercise. (3) Due to the ceiling imposed on the SAR grants, the exercisable amount equals a maximum of 1,192,123 shares of the Company’s common stock issuable upon exercise. As of June 30, 2016, there was $1,218 of unrecognized compensation expense related to unvested stock options and SARs. This amount is expected to be recognized over a weighted-average period of 1.3 years. To the extent the actual forfeiture rate is different from what the Company has estimated, equity-based compensation related to these awards will be different from the Company’s expectations. Starting in the second quarter of 2015, the Company granted to employees, including executive officers, and non-employee directors, restricted stock units (“RSUs”) under the Company’s 2011 Stock Incentive Plan. A RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three equal annual installments starting on the first anniversary of the grant date. RSUs granted to non-employee directors generally vest in full on the first anniversary of the grant date. The fair value of each RSU is the market value as determined by the closing price of the common stock on the day of grant. The Company recognizes compensation expenses for the value of its RSU awards, based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. A summary of the Company’s RSU activities and related information for the six months ended June 30, 2016, are as follows: Number of Weighted Average Unvested as of December 31, 2015 234,000 $ 19.89 Granted 338,100 20.79 Vested (64,640 ) 19.83 Forfeited or expired (3,967 ) 20.25 Unvested as of June 30, 2016 503,493 $ 20.50 Expected to vest after June 30, 2016 463,214 $ 20.49 As of June 30, 2016, there was $8,128 of unrecognized compensation expense related to unvested RSUs. This amount is expected to be recognized over a weighted-average period of 1.7 years. To the extent the actual forfeiture rate is different from what the Company has estimated, equity-based compensation related to these awards will be different from the Company’s expectations. The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of income: Six months ended Three months ended 2016 2015 2016 2015 (unaudited) (unaudited) (unaudited) (unaudited) Cost of revenue $ 114 $ 77 $ 54 $ 42 Research and development, net 1,421 885 775 494 Sales and marketing 502 244 255 165 General and administrative 1,046 470 525 126 Total equity-based compensation expense $ 3,083 $ 1,676 $ 1,609 $ 827 The fair value for the Company’s stock options and SARs (other than share issuances in connection with the employee stock purchase plan, as detailed below) granted to employees was estimated using the following assumptions: Six months ended Three months ended (unaudited) (unaudited) Expected dividend yield 0% 0% Expected volatility 33%-49% 34%-49% Risk-free interest rate 0.2%-2.0% 0.2%-2.0% Expected forfeiture 10% 10% Contractual term of up to 7 Years 7 Years Suboptimal exercise multiple 2.1 2.1 The Company did not grant any stock options or SARs during the three and six months ended June 30, 2016. The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions: Six months ended 2016 2015 (unaudited) (unaudited) Expected dividend yield 0% 0% Expected volatility 36%-57% 36% Risk-free interest rate 0.3%-0.5% 0.1% Expected forfeiture 0% 0% Contractual term of up to 24 months 24 months The Company did not grant any purchase rights under the 2002 employee stock purchase plan during the three months ended June 30, 2016 and 2015. |